WELLINGTON MANAGEMENT GROUP LLP - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 298 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$317,000
-4.5%
12,598
-21.1%
0.00%
Q3 2020$332,000
-70.6%
15,964
-66.5%
0.00%
Q2 2020$1,131,000
+121.8%
47,638
+67.9%
0.00%
Q1 2020$510,000
-25.4%
28,368
+45.3%
0.00%
Q1 2019$684,000
-78.9%
19,520
-64.0%
0.00%
-100.0%
Q2 2018$3,249,000
-62.5%
54,288
-71.3%
0.00%
-50.0%
Q1 2018$8,654,000
-6.5%
188,954
-18.7%
0.00%0.0%
Q4 2017$9,257,000
-4.8%
232,305
-4.4%
0.00%0.0%
Q3 2017$9,720,000
-9.2%
243,000
-2.2%
0.00%
-33.3%
Q2 2017$10,710,000
+51.5%
248,488
+10.0%
0.00%
+50.0%
Q1 2017$7,070,000
+44.4%
225,905
+16.5%
0.00%
+100.0%
Q4 2016$4,897,000
-49.9%
193,960
-51.0%
0.00%
-50.0%
Q3 2016$9,783,000
+121.6%
395,613
+82.5%
0.00%
+100.0%
Q2 2016$4,415,000
+96.7%
216,732
+47.3%
0.00%0.0%
Q1 2016$2,244,000
-28.9%
147,121
-37.3%
0.00%0.0%
Q4 2015$3,155,000
+128.3%
234,790
+138.3%
0.00%
Q3 2015$1,382,000
+210.6%
98,541
+276.0%
0.00%
Q2 2015$445,000
-16.5%
26,205
-62.9%
0.00%
Q4 2013$533,000
+0.4%
70,700
-2.5%
0.00%
Q3 2013$531,000
-42.1%
72,500
-49.2%
0.00%
Q2 2013$917,000142,7000.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders